Analystreport

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) had its price target lowered by analysts at Maxim Group from $8.00 to $5.00.

Brainstorm Cell Therapeutics Inc.  (BCLI) 
Last brainstorm cell therapeutics inc. earnings: 11/14 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.brainstorm-cell.com